154 related articles for article (PubMed ID: 22856138)
21. Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature.
Dark GG; Hill SA; Prise VE; Tozer GM; Pettit GR; Chaplin DJ
Cancer Res; 1997 May; 57(10):1829-34. PubMed ID: 9157969
[TBL] [Abstract][Full Text] [Related]
22. Multi-targeting NGR-modified liposomes recognizing glioma tumor cells and vasculogenic mimicry for improving anti-glioma therapy.
Huang D; Zhang S; Zhong T; Ren W; Yao X; Guo Y; Duan XC; Yin YF; Zhang SS; Zhang X
Oncotarget; 2016 Jul; 7(28):43616-43628. PubMed ID: 27283987
[TBL] [Abstract][Full Text] [Related]
23. A poly(l-glutamic acid)-combretastatin A4 conjugate for solid tumor therapy: Markedly improved therapeutic efficiency through its low tissue penetration in solid tumor.
Liu T; Zhang D; Song W; Tang Z; Zhu J; Ma Z; Wang X; Chen X; Tong T
Acta Biomater; 2017 Apr; 53():179-189. PubMed ID: 28167300
[TBL] [Abstract][Full Text] [Related]
24. Protein Corona Attenuates the Targeting of Antitumor Sialyl Lewis X-Decorated Liposomes to Vascular Endothelial Cells under Flow Conditions.
Onishchenko NR; Moskovtsev AA; Kobanenko MK; Tretiakova DS; Alekseeva AS; Kolesov DV; Mikryukova AA; Boldyrev IA; Kapkaeva MR; Shcheglovitova ON; Bovin NV; Kubatiev AA; Tikhonova OV; Vodovozova EL
Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376203
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and characterization of a photoresponsive doxorubicin/combretastatin A4 hybrid prodrug.
Liu W; Liang L; Zhao L; Tan H; Wu J; Qin Q; Gou X; Sun X
Bioorg Med Chem Lett; 2019 Feb; 29(3):487-490. PubMed ID: 30553736
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models.
Gabizon A; Amitay Y; Tzemach D; Gorin J; Shmeeda H; Zalipsky S
J Control Release; 2012 Jun; 160(2):245-53. PubMed ID: 22134116
[TBL] [Abstract][Full Text] [Related]
27. Combretastatin A-4 prodrug inhibits growth of human non-small cell lung cancer in a murine xenotransplant model.
Boehle AS; Sipos B; Kliche U; Kalthoff H; Dohrmann P
Ann Thorac Surg; 2001 May; 71(5):1657-65. PubMed ID: 11383817
[TBL] [Abstract][Full Text] [Related]
28. Peripherally cross-linking the shell of core-shell polymer micelles decreases premature release of physically loaded combretastatin A4 in whole blood and increases its mean residence time and subsequent potency against primary murine breast tumors after IV administration.
Wakaskar RR; Bathena SP; Tallapaka SB; Ambardekar VV; Gautam N; Thakare R; Simet SM; Curran SM; Singh RK; Dong Y; Vetro JA
Pharm Res; 2015 Mar; 32(3):1028-44. PubMed ID: 25223962
[TBL] [Abstract][Full Text] [Related]
29. Antimetastasis and antitumor efficacy promoted by sequential release of vascular disrupting and chemotherapeutic agents from electrospun fibers.
Luo X; Zhang H; Chen M; Wei J; Zhang Y; Li X
Int J Pharm; 2014 Nov; 475(1-2):438-49. PubMed ID: 25218185
[TBL] [Abstract][Full Text] [Related]
30. NQO1-selective activated prodrugs of combretastatin A-4: Synthesis and biological evaluation.
Zhang C; Qu Y; Ma X; Li M; Li S; Li Y; Wu L
Bioorg Chem; 2020 Oct; 103():104200. PubMed ID: 32890998
[TBL] [Abstract][Full Text] [Related]
31. Targeted treatment of choroidal neovascularization using integrin-mediated sterically stabilized liposomes loaded with combretastatin A4.
Ma L; Liu YL; Ma ZZ; Dou HL; Xu JH; Wang JC; Zhang X; Zhang Q
J Ocul Pharmacol Ther; 2009 Jun; 25(3):195-200. PubMed ID: 19456253
[TBL] [Abstract][Full Text] [Related]
32. Anticancer drug released from near IR-activated prodrug overcomes spatiotemporal limits of singlet oxygen.
Rajaputra P; Bio M; Nkepang G; Thapa P; Woo S; You Y
Bioorg Med Chem; 2016 Apr; 24(7):1540-9. PubMed ID: 26928287
[TBL] [Abstract][Full Text] [Related]
33. Antitumor activity of combretastatin-A4 phosphate, a natural product tubulin inhibitor.
Dorr RT; Dvorakova K; Snead K; Alberts DS; Salmon SE; Pettit GR
Invest New Drugs; 1996; 14(2):131-7. PubMed ID: 8913833
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, in vitro, and in vivo evaluation of phosphate ester derivatives of combretastatin A-4.
Hadimani MB; Hua J; Jonklaas MD; Kessler RJ; Sheng Y; Olivares A; Tanpure RP; Weiser A; Zhang J; Edvardsen K; Kane RR; Pinney KG
Bioorg Med Chem Lett; 2003 May; 13(9):1505-8. PubMed ID: 12699742
[TBL] [Abstract][Full Text] [Related]
35. The anti-angiogenic effect and novel mechanisms of action of Combretastatin A-4.
Su M; Huang J; Liu S; Xiao Y; Qin X; Liu J; Pi C; Luo T; Li J; Chen X; Luo Z
Sci Rep; 2016 Jun; 6():28139. PubMed ID: 27338725
[TBL] [Abstract][Full Text] [Related]
36. Site-specific and far-red-light-activatable prodrug of combretastatin A-4 using photo-unclick chemistry.
Bio M; Rajaputra P; Nkepang G; Awuah SG; Hossion AM; You Y
J Med Chem; 2013 May; 56(10):3936-42. PubMed ID: 23631389
[TBL] [Abstract][Full Text] [Related]
37. Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: in vitro and in vivo studies.
Zhang YF; Wang JC; Bian DY; Zhang X; Zhang Q
Eur J Pharm Biopharm; 2010 Mar; 74(3):467-73. PubMed ID: 20064608
[TBL] [Abstract][Full Text] [Related]
38. In-vitro stability and cytostatic activity of liposomal formulations of 5-fluoro-2'-deoxyuridine and its diacylated derivatives.
van Borssum Waalkes M; van Galen M; Morselt H; Sternberg B; Scherphof GL
Biochim Biophys Acta; 1993 May; 1148(1):161-72. PubMed ID: 8499464
[TBL] [Abstract][Full Text] [Related]
39. Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity.
Patil Y; Amitay Y; Ohana P; Shmeeda H; Gabizon A
J Control Release; 2016 Mar; 225():87-95. PubMed ID: 26809007
[TBL] [Abstract][Full Text] [Related]
40. Targeting of the antivascular drug combretastatin to irradiated tumors results in tumor growth delay.
Pattillo CB; Sari-Sarraf F; Nallamothu R; Moore BM; Wood GC; Kiani MF
Pharm Res; 2005 Jul; 22(7):1117-20. PubMed ID: 16028012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
